64 completed. 64 Phase 1, 24 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 64 | Completed 64 |
| Phase 2 | 24 | Completed 24 |
Follow Control: new trials by email Literature Review of Control trials Research Report on Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects CBP-0276 Acetate, Placebo for CBP-0276 Acetate - Healthy Volunteers | Phase 1 | Completed | Clarent Biopharma, Inc. | 64 | 2025-09-04 | 2026-10-16 |
| Nurse-Led Elderly Sleep Intervention Otago programme, Otago programme + Cognifit, Control - Sleep, Gerontology | Phase 1 / Phase 2 | Completed | University of Castilla-La Mancha | 66 | 2025-09-01 | 2026-05-22 |
| Effects of Platelet-Rich Fibrin on Postoperative Outcomes Following Nasosinusal Surgery Platelet-rich fibrin (PRF), Control - Turbinate Surgery | Phase 1 / Phase 2 | Completed | Hospital Edmundo Vasconcelos | 14 | 2024-06-15 | 2026-06-12 |
| Effect of Kinesio Tape Versus Systemic Dexamethasone on Postsurgical Sequels Following Extraction of Impacted Mandibular Third Molars Kinesio Tape application, Intramuscular Injection of Dexamethasone, control - Impacted Mandibular Third Molar Extraction | Phase 1 | Completed | Ashraf elanzy | 30 | 2023-10-01 | 2026-01-20 |
| Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults MAM01 1.5 mg/kg, Placebo, MAM01 5 mg/kg - Malaria | Phase 1 | Completed | Gates Medical Research Institute | 63 | 2023-08-14 | 2026-06-12 |
| Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs) PASC transplantation (25 million PASCs/patient), Control - Parkinson Disease | Phase 1 / Phase 2 | Completed | ClusterXStem-Costa Rica | 40 | 2023-06-23 | 2026-10-22 |
| A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults Low dose multivalent pneumococcal conjugate vaccine formulation A, Low dose multivalent pneumococcal conjugate vaccine formulation B, Low dose of multivalent pneumococcal conjugate vaccine control - Pneumococcal Disease | Phase 1 | Completed | Pfizer | 90 | 2023-04-19 | 2024-07-29 |
| Montmorency Cherry Supplementation, Sleep, and Inflammation Montmorency cherry supplement, Control - Insomnia Chronic, Inflammation | Phase 1 / Phase 2 | Completed | Michigan State University | 34 | 2023-02-18 | 2025-09-08 |
| Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects Placebo, PRS-220 - Healthy | Phase 1 | Completed | Pieris Australia Pty Ltd | 64 | 2022-10-31 | 2023-10-23 |
| Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance. UC-MSCs, Secretomes, UC-MSCs and Secretomes - Polycystic Ovary Syndrome | Phase 1 / Phase 2 | Completed | PT. Prodia Stem Cell Indonesia | 44 | 2022-09-01 | 2026-02-25 |
| An Adaptive Walking Intervention to Manage Chronic Pain in Veterans With Opioid Use Disorder Engaged in Opioid Agonist Treatment Steps 2 Change (S2C), Control - Opioid Use Disorder, Chronic Pain | Phase 1 | Completed | VA Office of Research and Development | 60 | 2022-04-01 | 2026-02-04 |
| Safety and Pharmacokinetics of SAD/MAD Oral Doses of SRP-3D (DA) SRP-3D (diethylamide), Placebo - Pain | Phase 1 | Completed | South Rampart Pharma, Inc. | 50 | 2021-12-30 | 2026-09-10 |
| Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19 Placebo, Anti-SARS-CoV-2 equine immunoglobulin F(ab')2 fragments (INOSARS) - COVID-19 | Phase 1 | Completed | TecSalud Investigación Clínica | 32 | 2021-12-07 | 2023-01-26 |
| N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) N-acetyl glucosamine (NAG), Control - Coronavirus, Covid19 | Phase 1 | Completed | Quantinosis.ai LLC | 150 | 2020-11-14 | 2023-04-04 |
| A Personalized Behavioral Intervention to Improve Physical Activity, Sleep and Cognition in Sedentary Older Adults ELDERFITNESS, Control - Sleep | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 129 | 2019-07-11 | 2023-03-08 |
| Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes ProTrans, Control - Type1diabetes | Phase 1 / Phase 2 | Completed | NextCell Pharma Ab | 15 | 2019-05-17 | 2025-03-07 |
| Coated Devices to Decrease Infection in the Intensive Care Unit Coated devices, Control - Critically Ill | Phase 1 / Phase 2 | Completed | Hospital do Coracao | 103 | 2019-04-06 | 2020-03-09 |
| Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study) Amoxicillin, Azithromycin, Control - Normal Physiology, Healthy | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 108 | 2017-03-22 | 2026-05-28 |
| Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes Dapagliflozin, Placebo Oral Tablet - Type1diabetes | Phase 1 | Completed | Kinderkrankenhaus auf der Bult | 30 | 2017-02-09 | 2024-10-15 |
| Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans Endotoxin, Placebo - Healthy | Phase 1 | Completed | Robert J Noveck, M.D. | 23 | 2016-08-01 | 2017-04-11 |
Showing 20 of 64. Sign in to see all of them.
Motor Activity (7) · Diabetes Mellitus, Type 1 (3) · Parkinson Disease (3) · COVID-19 (2) · Diabetes Mellitus (2) · Myocardial Infarction (2) · Ovarian Hyperstimulation Syndrome (2) · Peripheral Arterial Disease (2) · Agnosia (1) · Alopecia (1) · Alveolar Bone Loss (1) · Anthrax (1) · Arthritis (1) · Body Weight (1) · Brain Injuries (1)
Royan Institute (3) · Washington University School of Medicine (3) · Affiris AG (2) · Kinderkrankenhaus auf der Bult (2) · Mayo Clinic (2) · Pfizer (2) · University of Isfahan (2) · VA Office of Research and Development (2) · Ashraf elanzy (1) · AstraZeneca (1) · Boston Scientific Corporation (1) · Center for Veterans Research and Education (1) · Clarent Biopharma, Inc. (1) · ClusterXStem-Costa Rica (1) · Emergent BioSolutions (1)
United States (30) · Canada (7) · United Kingdom (4) · Germany (3) · Iran (3) · Austria (2) · Brazil (2) · Mexico (2) · Spain (2) · Australia (1) · Bangladesh (1) · Bulgaria (1) · Costa Rica (1) · Czechia (1) · Egypt (1)
Ashraf Moini, MD (2) · Burton M Wice, PhD (2) · Dominic Reeds, MD (2) · Marzieh Shiva, MD (2) · Santiago A Garcia, MD (2) · Thomas Danne, MD (2) · Alexandre Biasi, MD/PhD (1) · Amin R Javer, MD, FRCSC (1) · Ann C Skulas-Ray, PhD (1) · Berthold Bein, MD (1) · Bruce A Buckingham, MD (1) · Cathy M Arnold, MSc (1) · Christa S Zerbe, M.D. (1)
PMID 30741694, PMID 15125017, PMID 17707752, PMID 19508973, PMID 19559969, PMID 19794023, PMID 20418657, PMID 22231013, PMID 22505632, PMID 22776413, PMID 23701746, PMID 23741380, PMID 24429129, PMID 24712447, PMID 24997137, PMID 25064164, PMID 25252696, PMID 25722291, PMID 25853697, PMID 26545726, PMID 27222506, PMID 27288245, PMID 27322478, PMID 27688236, PMID 27777606, PMID 28254171, PMID 28356431, PMID 28591764, PMID 28735720, PMID 28939263, PMID 29659952, PMID 30906944, PMID 32526149, PMID 34306677, PMID 36645250, PMID 37251511, PMID 39272232, PMID 41005346, PMID 41925207, PMID 42775498
2014 (1), 2018 (1), IK2CX002286 (1), R00NR016484 (1), R01DK088126 (1), R01MH062717 (1), R01NS052448 (1), R21CA152433 (1)